✦ LIBER ✦

Hypertension, Renal Disease, and Cardiovascular Outcomes

✍ Scribed by Marvin Moser; Jan Basile; William Cushman

Book ID: 115306245
Publisher: Le Jacq Communications, Inc.
Year: 2005
Tongue: English
Weight: 125 KB
Volume: 7
Category: Article
ISSN: 1524-6175
DOI: 10.1111/j.1524-6175.2005.04702.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The Advanced Glycation End Product Nε-Ca

The Advanced Glycation End Product Nε-Carboxymethyllysine Is Not a Predictor of Cardiovascular Events and Renal Outcomes in Patients With Type 2 Diabetic Kidney Disease and Hypertension

✍ Martin Busch; Sybille Franke; Gunter Wolf; Antje Brandstädt; Undine Ott; Jens Ge 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 130 KB

Hypertension and future cardiovascular d

Hypertension and future cardiovascular disease in pediatric renal transplant recipients

✍ Joseph T. Flynn 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB

Obesity hypertension: a risk factor for

Obesity hypertension: a risk factor for cardiovascular and renal disease

✍ Efrain Reisin 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 113 KB

Prevalence and outcomes of diabetes, hyp

Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD

✍ Mannino, D. M.; Thorn, D.; Swensen, A.; Holguin, F. 📂 Article 📅 2008 🏛 European Respiratory Society 🌐 English ⚖ 289 KB

Association of Hyperuricemia with Renal

Association of Hyperuricemia with Renal Outcomes, Cardiovascular Disease, and Mortality

✍ Liu, W.-C.; Hung, C.-C.; Chen, S.-C.; Yeh, S.-M.; Lin, M.-Y.; Chiu, Y.-W.; Kuo, 📂 Article 📅 2012 🏛 American Society of Nephrology 🌐 English ⚖ 527 KB

EXPERIMENTAL KALLIKREIN GENE THERAPY IN

EXPERIMENTAL KALLIKREIN GENE THERAPY IN HYPERTENSION, CARDIOVASCULAR AND RENAL DISEASES

✍ J. CHAO; L. CHAO 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 71 KB